Vr Adviser, LLC Viridian Therapeutics, Inc.\De Transaction History
Vr Adviser, LLC
- $966 Million
- Q3 2024
A detailed history of Vr Adviser, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Vr Adviser, LLC holds 3,882,709 shares of VRDN stock, worth $75.5 Million. This represents 9.15% of its overall portfolio holdings.
Number of Shares
3,882,709
Previous 3,882,671
-0.0%
Holding current value
$75.5 Million
Previous $50.5 Million
74.87%
% of portfolio
9.15%
Previous 5.54%
Shares
11 transactions
Others Institutions Holding VRDN
# of Institutions
178Shares Held
76.6MCall Options Held
581KPut Options Held
439K-
Black Rock Inc. New York, NY4.77MShares$92.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$86 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.75MShares$73 Million3.15% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$67 Million12.74% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.9MShares$56.3 Million2.37% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $776M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...